Virus infection induced pulmonary fibrosis.
Wei Jie HuangXiao Xiao TangPublished in: Journal of translational medicine (2021)
Pulmonary fibrosis is the end stage of a broad range of heterogeneous interstitial lung diseases and more than 200 factors contribute to it. In recent years, the relationship between virus infection and pulmonary fibrosis is getting more and more attention, especially after the outbreak of SARS-CoV-2 in 2019, however, the mechanisms underlying the virus-induced pulmonary fibrosis are not fully understood. Here, we review the relationship between pulmonary fibrosis and several viruses such as Human T-cell leukemia virus (HTLV), Human immunodeficiency virus (HIV), Cytomegalovirus (CMV), Epstein-Barr virus (EBV), Murine γ-herpesvirus 68 (MHV-68), Influenza virus, Avian influenza virus, Middle East Respiratory Syndrome (MERS)-CoV, Severe acute respiratory syndrome (SARS)-CoV and SARS-CoV-2 as well as the mechanisms underlying the virus infection induced pulmonary fibrosis. This may shed new light on the potential targets for anti-fibrotic therapy to treat pulmonary fibrosis induced by viruses including SARS-CoV-2.
Keyphrases
- pulmonary fibrosis
- sars cov
- epstein barr virus
- human immunodeficiency virus
- respiratory syndrome coronavirus
- high glucose
- antiretroviral therapy
- diabetic rats
- endothelial cells
- hepatitis c virus
- diffuse large b cell lymphoma
- hiv infected
- hiv positive
- drug induced
- stem cells
- hiv aids
- risk assessment
- oxidative stress
- working memory
- systemic sclerosis
- idiopathic pulmonary fibrosis
- mesenchymal stem cells
- genetic diversity
- hiv testing
- men who have sex with men
- induced pluripotent stem cells
- pluripotent stem cells